Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country
Clinical trial NCT05644067 · COMPLETED
Trial details
- NCT number
- NCT05644067
- Sponsor
- Swiss Tropical & Public Health Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-25
- Primary completion
- 2024-04-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.